MADHAVBAUG — Vaidya Sane Ayurved Laboratories Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapHigh Flyer

Annual income statement for Vaidya Sane Ayurved Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2021 March 31st	2022 March 31st	R2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	523	747	992	993	898
Cost of Revenue
Gross Profit	346	516	715	736	731
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	515	699	934	975	814
Operating Profit	7.54	48	57.4	17.9	84.5
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	4.55	47.5	64.3	28.6	99
Provision for Income Taxes
Net Income After Taxes	3.92	34.7	48.3	19.9	71.5
Minority Interest
Equity in Affiliates
Net Income Before Extraordinary Items
Net Income	3.92	34.7	48.3	19.8	71.4
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	3.92	34.7	48.3	19.8	71.4
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.403	3.3	4.6	1.56	6.49
Dividends per Share